M-BACOD regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: m-BACOD Regimen; Methotrexate-Bleomycin-Adriamycin-Cytoxan-Oncovin-Decadron Regimen
Overview
Overview
M-BACOD regimen refers to a regimen consisting of methotrexate, bleomycin, doxorubicin (adriamycin), cyclophosphamide, vincristine and dexamethasone used to treat aggressive forms of non-Hodgkin’s lymphoma.[1][2]
Regimen
Regimen
MMethotrexate
BBleomycin
ADoxorubicin (Adriamycin)
CCyclophosphamide
OVincristine (Oncovin)
DDexamethasone
References
References
- ↑ “NCI Thesaurus”.
- ↑ 2.0 2.1 Shipp MA, Yeap BY, Harrington DP, Klatt MM, Pinkus GS, Jochelson MS; et al. (1990). “The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen”. J Clin Oncol. 8 (1): 84–93. PMID 1688615.
- ↑ “NCI Thesaurus”.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH